Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q4 2018 Earnings

6NovConfirmed

Q1 2018

Q2 2018

Q3 2018

Q4 2018

-0.57

-0.53

-0.48

-0.44

Details

Expected EPS

-0.57

Actual EPS

-0.5

Surprise EPS

0.07

Surprise Percent

+12.28%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.5 per share for Q4 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.